These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11959194)

  • 1. Increased frequency of tuberculosis in Mexican renal transplant recipients: a single-center experience.
    Melchor JL; Gracida C; Ibarra A
    Transplant Proc; 2002 Feb; 34(1):78-9. PubMed ID: 11959194
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of proteinuria in cyclosporine-treated cadaveric renal transplant recipients.
    Koay HC; Vathsala A; Woo KT
    Transplant Proc; 2000 Nov; 32(7):1921-3. PubMed ID: 11120001
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycobacterium tuberculosis infection in renal transplant recipients.
    Ergun I; Ekmekci Y; Sengul S; Kutlay S; Dede F; Canbakan B; Erbay B
    Transplant Proc; 2006 Jun; 38(5):1344-5. PubMed ID: 16797298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical worsening of tuberculosis after anti-TB therapy in a kidney transplant recipient.
    Asano T; Kawamoto H; Asakuma J; Tanimoto T; Kobayashi H; Hayakawa M
    Transplant Proc; 2000 Nov; 32(7):1960-2. PubMed ID: 11120020
    [No Abstract]   [Full Text] [Related]  

  • 5. Tuberculosis in renal transplant recipients.
    Arslan H; Ergin F; Oner-Eyuboglu F; Akcay S; Karakayali H; Haberal M
    Transplant Proc; 2003 Nov; 35(7):2680-1. PubMed ID: 14612070
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
    Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
    Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area.
    Gras J; De Castro N; Montlahuc C; Champion L; Scemla A; Matignon M; Lachâtre M; Raskine L; Grall N; Peraldi MN; Molina JM
    Transpl Infect Dis; 2018 Oct; 20(5):e12943. PubMed ID: 29890021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis after renal transplantation.
    Sharma AK; Tolani SL; Rathi GL; Gupta HP; Gupta R
    Transplant Proc; 2000 Nov; 32(7):1959. PubMed ID: 11120019
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Douzdjian V; Escobar F; Mozes M; Abouljoud M
    Transplant Proc; 1999; 31(1-2):1131-2. PubMed ID: 10083505
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with Simulect.
    Henry ML; Pelletier RP
    Transplant Proc; 2004 Mar; 36(2 Suppl):471S-474S. PubMed ID: 15041390
    [No Abstract]   [Full Text] [Related]  

  • 12. Extrapulmonary involvement of mycobacterial infections in dialysis patients.
    Oner-Eyüboglu AF; Akçay MS; Arslan H; Demirhan B; Kalpaklioglu AF
    Transplant Proc; 1999 Dec; 31(8):3199-201. PubMed ID: 10616438
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term survival of cadaveric renal transplantation: a clinical analysis in a local renal transplantation center.
    Li CD; Wen ZL; Yan YR; Cai Y
    Transplant Proc; 1998 Nov; 30(7):3092-3. PubMed ID: 9838364
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
    Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors.
    Mulloy LL; Wright F; Hall ML; Moore M
    Transplant Proc; 1999; 31(1-2):1210-3. PubMed ID: 10083541
    [No Abstract]   [Full Text] [Related]  

  • 16. Early graft dysfunction developed within one week after renal allograft.
    Kim SC; Jang HJ; Kim SK; Kim TH; Yoo ES; Jung JG; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1886-7. PubMed ID: 11119985
    [No Abstract]   [Full Text] [Related]  

  • 17. Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.
    Ben Hamida M; Bedrossian J; Pruna A; Fouqueray B; Metivier F; Idatte JM
    Transplant Proc; 1993 Jun; 25(3):2290-1. PubMed ID: 8516902
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute rejection episodes predict long-term renal transplantation survival.
    Kokado Y; Takahara S; Hatori M; Ichimaru I; Wang JD; Miki T; Okuyama A
    Transplant Proc; 1997; 29(1-2):1537-40. PubMed ID: 9123416
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis in renal transplant recipients.
    Dridi A; Kaaroud H; Boubaker K; Abdallah TB; El-Younsi F; Moussa FB; Hidri H; Abderrahim E; Khedher A; Ben Maïz H
    Transplant Proc; 2003 Nov; 35(7):2682-3. PubMed ID: 14612071
    [No Abstract]   [Full Text] [Related]  

  • 20. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.